Wikipedia -WSS

Wikipedia

author：explore 2025-08-08 05:33:06 - browse：468

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： He's a Nobel laureate. Critics say he was misleading on Covid

focus

WSS

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Medicare inequities exacerbate Puerto Rico’s health disparities

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Antivenom research: Lessons from HIV applied in search for universal antidote

New chief aims to remake Sanofi Genzyme

knowledge

Wikipedia

leisure time

Jerome Adams on the need for new antivirals for Covid

The Harvard botanist who searched for psychedelics in the Amazon

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A new nitrogen execution bill also undermines medical licensing

Walensky prepares to leave CDC — and Congress — behind

It's time to take a new tack for treating Alzheimer's

ChatGPT in medicine: STAT answers readers' burning questions

The Harvard botanist who searched for psychedelics in the Amazon

United colonoscopy coverage change 'may cost lives,' doctors say

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

explore

Trump Organization, Michael Cohen agree to settle million

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

The Harvard botanist who searched for psychedelics in the Amazon

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Alabama IVF ruling threatens families facing fatal genetic disease

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

focus

hotspot

knowledge

focus